Priority Review
Priority Review is a regulatory designation within the drug approval process that accelerates the evaluation timeline for a pharmaceutical product to address unmet medical needs or demonstrate significant therapeutic advantages over existing treatments.
78
Publications
3.6K
Citations
319
Authors
204
Institutions
Publications per year
2017–2026
34
Parents
78
FDA Approval and Regulation of Pharmaceuticals, 1983-2018
Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim · JAMA · 2020 · 362 citations
Priority setting: lessons from Oregon
Justin Dixon, H. Gilbert Welch · The Lancet · 1991 · 213 citations
Candyce Hamel, Shannon Kelly, Kednapa Thavorn et al. · BMC Medical Research Methodology · 2020 · 141 citations · Full text
1–5 of 78
319
7
h-index
3
h-index
3
h-index
3
h-index
3
h-index
1–5 of 319
204

Brigham and Women's Hospital
Boston, United States
9 h-index
22 publications
2.6K citations
Duke University
Durham, United States
4 h-index
6 publications
139 citations
United States Food and Drug Administration
Silver Spring, United States
4 h-index
10 publications
206 citations
Harvard University
Cambridge, United States
3 h-index
10 publications
2K citations

University of Ottawa
Ottawa, Canada
3 h-index
8 publications
772 citations
Ottawa Hospital Research Institute
Ottawa, Canada
3 h-index
9 publications
899 citations

Ottawa Hospital
Ottawa, Canada
3 h-index
11 publications
1K citations

University of Minnesota
Minneapolis, United States
3 h-index
11 publications
387 citations
1–8 of 204
6 publications · 659 citations
7
h-index
5 publications · 190 citations
5
h-index
4 publications · 139 citations
4
h-index
4 publications · 211 citations
4
h-index
Repository · 3 publications · 58 citations
3
h-index
1–5